Biliary liver cirrhosis, also known as primary biliary cholangitis (PBC), is a chronic liver disease characterized by progressive inflammation and destruction of the small bile ducts within the liver. This condition primarily affects middle-aged women, although it can occur in individuals of any age or gender.
The liver plays a vital role in the digestion and metabolism of fats. Bile ducts transport bile, a substance produced by the liver that aids in the digestion and absorption of fats, from the liver to the small intestine. In the case of biliary liver cirrhosis, the immune system mistakenly attacks and destroys the bile ducts, leading to impaired bile flow and accumulation of toxins in the liver.
As the disease progresses, the liver becomes scarred and replaced by fibrous tissue, resulting in cirrhosis. This can lead to a range of symptoms, including fatigue, itching, jaundice (yellowing of the skin and eyes), abdominal pain, and fluid retention. Ultimately, biliary liver cirrhosis can lead to liver failure if left untreated.
Treatment for biliary liver cirrhosis focuses on managing symptoms, slowing the progression of the disease, and preventing complications. Medications can be prescribed to reduce inflammation, manage symptoms, and improve the flow of bile. Liver transplantation may be considered in severe cases where the liver can no longer function properly.
Regular monitoring and follow-up with healthcare professionals are essential for individuals diagnosed with biliary liver cirrhosis to ensure appropriate management of the disease and to reduce the risk of complications.
